We are live on ! Find out more

182 hedge funds and large institutions have $1.18B invested in CareDx in 2019 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 53 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

252% more call options, than puts

Call options by funds: $8.62M | Put options by funds: $2.45M

189% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 18

29% more capital invested

Capital invested by funds: $914M → $1.18B (+$268M)

23% more funds holding

Funds holding: 148182 (+34)

0.71% more ownership

Funds ownership: 89.14%89.86% (+0.71%)

7% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 57

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
182
Holders Change
+34
Holders Change %
+22.97%
% of All Funds
3.93%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.13%
New
52
Increased
53
Reduced
57
Closed
18
Calls
$8.62M
Puts
$2.45M
Net Calls
+$6.17M
Net Calls Change
+$4.31M

CDNA Hedge Fund Activity: Q1 2019 in Review

182 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q1 2019, worth a combined $1.18B — up 29% from $914M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new CDNA positions and 18 closed out — a net gain of 34 holders — while 53 added to existing stakes and 57 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $24.1M. The largest seller was ISZO Capital Management, cutting an estimated $28.2M.

  • 182 institutional investors held CareDx (CDNA) as of Q1 2019, up from 148 in Q4 2018.
  • Funds reported $1.18B of CareDx stock for Q1 2019, up 29% quarter-over-quarter.
  • 52 funds opened new CareDx positions in Q1 2019 and 18 closed out, a net change of +34 holders.
  • The largest CareDx buyer in Q1 2019 was OrbiMed, an estimated $24.1M added.
  • The largest CareDx seller in Q1 2019 was ISZO Capital Management, an estimated $28.2M sold.

Based on aggregated 13F filings for Q1 2019.